News Alert

Novartis Says it Plans to Still Partake in HRSA’s 340B Rebate Pilot; Providers, Drug Industry Diverge on Approvals 

Provider advocates criticized HRSA's recent 340B rebate pilot approvals, while the drug industry generally applauded the move.

The sole eligible drugmaker not included in the Health Resources and Services Administration’s (HRSA) 340B rebate pilot said it plans [...]

Continue Reading

Breaking News

HRSA Approves 340B Rebate Proposals for Nine Drugs Under Pilot Program, Expands Data Requirements

HRSA on Oct. 30 announced that it had approved eight drugs for its 340B rebate pilot program.

The Health Resources and Services Administration (HRSA) on Thursday approved 340B rebate models for nine drugs under its controversial 340B [...]

Continue Reading

Exclusive

House Lawmakers in Talks to Launch Bipartisan 340B Working Group as Counterpart to Senate ‘Gang of Six’

Some U.S. House members are said to be in early discussions to form a bipartisan 340B working group.

Several U.S. House lawmakers are in early talks to form a bipartisan 340B working group as a counterpart to the [...]

Continue Reading

Trump Administration to Accelerate Biosimilar Development; PhRMA Points to PBMs, 340B Program for Slow Uptake

HHS Secretary Robert F. Kennedy Jr. (center), CMS Administrator Mehmet Oz (right) and FDA Commissioner Marty Makary (left) announced biosimilar reform plans at a Wednesday HHS news conference.

Federal health officials on Wednesday announced new biosimilar reform efforts, which aim to more quickly and cheaply develop the lower [...]

Continue Reading
Industry Insights Logo

Is Your 340B Partner a Good Fit? Look for These Signs

SPONSORED CONTENT Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit [...]

Continue Reading

How New Direct-to-Consumer Drug Platforms like TrumpRx Could Affect 340B

President Donald Trump, Pfizer CEO Albert Bourla and others on Sept. 30 announced a voluntary agreement involving TrumpRx, a new direct-to-consumer prescription drug platform. (Photo credit: White House video screenshot)

Direct-to-consumer drug platforms, like President Donald Trump’s new TrumpRx, could impact the cost of 340B prescription drugs by potentially affecting [...]

Continue Reading

Federal Judge Who Upheld Arkansas’ First-in-Nation 340B Contract Pharmacy Law Dies at 85

Arkansas Attorney General Tim Griffin (R) posted a photo paying homage to U.S. District Judge Billy Roy Wilson, of the Eastern District of Arkansas, who died Oct. 27. (Photo courtesy: Griffin's X post)

The longtime federal judge behind a landmark ruling that upheld Arkansas’ first-in-the-nation 340B contract pharmacy access law died this week [...]

Continue Reading

State Contract Pharmacy Lawsuit Roundup: New Filings in Tennessee and Colorado 

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Tennessee and Colorado.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Continue Reading

Publisher’s Column: The Government Shutdown’s Casualties

A sign outside a Virginia home urges support for federal workers.

As a longtime resident of the Washington, D.C., area, I am acutely aware of the federal government’s impact on the [...]

Continue Reading

Exclusive

Novartis is Second Drugmaker to End 340B Pricing for STD Clinics

340B Report reviewed a letter Novartis sent to an STD covered entity outlining its plans to end 340B pricing for STD clinics.

Novartis has begun informing STD clinics that they will lose access to 340B pricing for all of the company’s products [...]

Continue Reading
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives